amgen glp-1 obesity drug market potential Global Receptor Agonist Size, Forecast Market Overview: GLP-1 Agonists and
Description
The first is the obesity epidemic
Beyond its primary location in pancreatic -cells, GLP-1 receptor (GLP-1R) has been identified in various other tissues, including the gastrointestinal tract, lung, kidney, heart, bone, central nervous system, liver, and adipose tissue (Bu et al., 2024)
Regarding renal effects, the evidence of SGLT2is in preventing kidney failure is more abundant than for GLP-1RAs, which showed a beneficial effect on albuminuria but not on hard kidney endpoints
An oral version could make these medications easier for many people to use
